Financial Consulate’s Pfizer PFE Stock Holding History

Financial Consulate’s Portfolio PFE Stock Details PFE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$48.6K	Sell	2,017 -209	-9%	-$5.47K	0.01%	357
2026 Q1	$62.5K	Buy	2,226 +383	+21%	+$10.2K	0.01%	288
2025 Q4	$45.9K	Sell	1,843 -982	-35%	-$24.8K	0.01%	333
2025 Q3	$72K	Buy	+2,825	New	+$69.7K	0.01%	274
2015 Q1	–	Sell	-7,573	Closed	-$224K	–	65
2014 Q4	$224K	Buy	+7,573	New	+$217K	0.15%	65

Other funds holding PFE

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Financial Consulate's PFE Position: Q2 2026 in Review

Financial Consulate reduced its Pfizer (PFE) stake by 9.4% in Q2 2026, selling an estimated $5.47K and leaving 2,017 shares worth $48.6K. The position accounts for 0.01% of the portfolio, ranked #357.

Financial Consulate first reported a position in PFE in Q4 2014 and has held it in 5 quarters since. The position peaked at $224K in Q4 2014. 2,818 funds tracked by Wall St. Rank hold PFE as of Q2 2026.

Financial Consulate held 2,017 shares of Pfizer worth $48.6K as of Q2 2026.
Financial Consulate sold 209 Pfizer shares in Q2 2026, an estimated $5.47K.
Pfizer made up 0.01% of Financial Consulate's portfolio in Q2 2026, its #357 holding.
Financial Consulate first reported a position in Pfizer in Q4 2014 and has held it in 5 quarters since.
Financial Consulate's Pfizer position peaked at $224K in Q4 2014.
2,818 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.

Based on Financial Consulate's 13F filing for Q2 2026, filed 23 Jul 2026.